 |
|
Therapeutics for the treatment of coronavirus disease 2019 in children and adolescents
Soo-Han Choi, Jae Hong Choi, Ki Wook Yun
Clin Exp Pediatr. 2022;65(8):377-386. Published online 2022 Jun 27 DOI: https://doi.org/10.3345/cep.2022.00458
|
|
Citations to this article as recorded by
 Community-acquired pneumonia in children: updated perspectives on its etiology, diagnosis, and treatment
Ki Wook Yun
Clinical and Experimental Pediatrics.2024; 67(2): 80. CrossRef Treatment with Remdesivir of Children with SARS-CoV-2 Infection: Experience from a Clinical Hospital in Romania
Maria-Elena Cocuz, Iuliu Gabriel Cocuz, Ligia Rodina, Elena Tataranu, Olga Adriana Caliman-Sturdza, Florin Filip
Life.2024; 14(3): 410. CrossRef Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan
Tomohiro Katsuta, Yuta Aizawa, Kensuke Shoji, Naoki Shimizu, Kenji Okada, Takashi Nakano, Hajime Kamiya, Kiyoko Amo, Naruhiko Ishiwada, Satoshi Iwata, Makoto Oshiro, Nobuhiko Okabe, Seigo Korematsu, Shigeru Suga, Takeshi Tsugawa, Naoko Nishimura, Haruka H
Pediatric Infectious Disease Journal.2023; 42(3): 240. CrossRef Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit
Olga Nigro, Chiara Oltolini, Federica Barzaghi, Caterina Uberti Foppa, Maria Pia Cicalese, Maura Massimino, Elisabetta Schiavello
Expert Review of Anticancer Therapy.2023; 23(9): 927. CrossRef Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies
Eun Kyo Ha, Ju Hee Kim, Man Yong Han
Clinical and Experimental Pediatrics.2023; 66(11): 465. CrossRef
|